Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Leticia R. Cruz, Idania Baladrón, Aliusha Rittoles, Pablo A. Díaz, Carmen Valenzuela, Raúl Santana, Maria M. Vázquez, Ariadna García, Deyli Chacón, Delvin Thompson, Gustavo Perera, Ariel González, Rafael Reyes, Loida Torres, Jesus Pérez, Yania Valido, Ralysmay Rodriguez, Dania M. Vázquez, Mauro Rosales, Ailyn C. Ramón, George V. Pérez, Gerardo Guillén, Verena Muzio, Yasser Perera, Silvio E. Perea, for the ATENEA-Co-300 group
medRxiv 2020.09.03.20187112; doi: https://doi.org/10.1101/2020.09.03.20187112
